Award
Delivery Order #SPE2DR26F69N5
Delivery Order for Pharmaceutical Suspension from AmerisourceBergen Drug Corp
Buyer
Defense Logistics Agency
Award Amount
$763.44
Ceiling
$763.44
Awarded
February 27, 2026
Period of Performance
Feb 27, 2026 – Mar 02, 2026
Identifier
SPE2DR26F69N5
NAICS
424210
This FPDS award represents a delivery order contract under an existing Indefinite Delivery Vehicle (IDV) with AmerisourceBergen Drug Corporation, a leading pharmaceutical distributor specializing in supplying critical medications. The contract procures a specific pharmaceutical product—Quillivant XR 25 MG/5 ML Suspension in a 120 ML volume—intended to bolster government healthcare services. Its significance lies in supporting timely access to essential medications, directly impacting public health and safety. The work scope includes the delivery and supply of this pharmaceutical product within a short-term period, ensuring urgent healthcare needs are met. This contract was awarded as a delivery order under the parent IDV, indicating a competitive and structured procurement process. Key dates include the recent award period spanning early 2026. The parent IDV contract underpins this order, further highlighting the ongoing collaboration to maintain pharmaceutical supply availability for government healthcare operations.
Description
4570985550!QUILLIVANT XR 25 MG/5 ML SUSP 120ML